Neurones S.A. (NRO)
Euronext
39.75
-0.55 (-1.36%)
Closed
Nov 6, 2026
Day's Range
39.1540.35
52 wk Range
31.9045.00
Financial Statements - NRO - Neurones S.A.
Revenue
857.17M▲ 5.8%
Net Income
61.85M▼ 2.2%Net Margin 7.2%
EBITDA
105.99M▼ 1.2%
Free Cash Flow
60.84M▼ 15.9%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 857.17M | 810.35M | 741.17M | 665.37M | 579.87M | 524.48M |
| Cost of Goods | 315.32M | 304.17M | 284.46M | 256.16M | 231.64M | 212.04M |
| Gross Profit | 541.85M | 506.17M | 456.71M | 409.21M | 348.23M | 312.44M |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | 75.78M | 78M | 75.02M | 71.94M | 61.55M | 51.05M |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | - | - | - | - | - | - |
| Pre Tax Income | 85.07M | 88.11M | 80.76M | 72.86M | 61.75M | 53.56M |
| Income Tax | 23.21M | 24.88M | 22.18M | 21.09M | 18.81M | 18.57M |
| Net Income | 61.85M | 63.22M | 58.58M | 51.77M | 42.94M | 34.98M |
| EPS Basic | 2.14 | 2.162834 | 2.04 | 1.83 | 1.56 | 1.27 |
| EPS Diluted | 2.14 | 2.162834 | 2.03 | 1.82 | 1.56 | 1.27 |
| Basic Shares Outstanding | 24.30M | 24.27M | 24.23M | 24.22M | 24.21M | 24.23M |
| Diluted Shares Outstanding | 24.30M | 24.27M | 24.23M | 24.22M | 24.21M | 24.23M |
| Ebit | 86.83M | 89.92M | 82.19M | 74.56M | 62.72M | 54.58M |
| Ebitda | 105.99M | 107.33M | 97.36M | 90.43M | 77.59M | 68.66M |
| Net Income Continuous Operations | 61.85M | 63.22M | 58.58M | 51.77M | 42.94M | 34.98M |
| Minority Interests | -9.78M | -10.67M | -9.17M | -7.52M | -5.23M | -4.06M |
| Preferred Stock Dividends | 0 | 0 | 0 | 0 | 0 | 0 |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
